Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 28, 2011 - Issue 1
537
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Expression of Circadian Clock and Melatonin Receptors within Cultured Rat Cardiomyocytes

, , , , &
Pages 21-30 | Received 15 Apr 2010, Accepted 06 Sep 2010, Published online: 23 Dec 2010

REFERENCES

  • Afeche SC, Amaral FG, Villela DCM, Abrahão MV, Peres R, Cipolla-Neto J. (2008). Melatonin and pineal gland. In E Romano, S De Luca (eds.). New research on neurosecretory systems. Hauppauge, NY: Nova Science Publishers, 155–177.
  • Agez L, Laurent V, Pévet P, Masson-Pévet M, Gauer F. (2007). Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei. Neuroscience 144:522–530.
  • Akashi M, Takumi T. (2005). The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1. Nat. Struct. Mol. Biol. 12:441–448.
  • Alonso-Vale MI, Andreotti S, Mukai PY, Borges-Silva CN, Peres SB, Cipolla-Neto J, Lima FB. (2008). Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J. Pineal Res. 45:422–429.
  • Arendt J. (1995). Effects of melatonin: therapeutic potential and significance to human health. In J Arendt. (ed.). Melatonin and the mammalian pineal gland. London: Chapman & Hall, 247–285.
  • Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED. (2002). Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest. 109:629–639.
  • Bertuglia S, Reiter RJ. (2007). Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters. J. Pineal Res. 42:55–63.
  • Bray MS, Shaw CA, Moore MW, Garcia RA, Zanquetta MM, Durgan DJ, Jeong WJ, Tsai JY, Bugger H, Zhang D, Rohrwasser A, Rennison JH, Dyck JR, Litwin SE, Hardin PE, Chow CW, Chandler MP, Abel ED, Young ME. (2008). Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am. J. Physiol. Heart Circ. Physiol. 294:H1036–H1047.
  • Chomczynski P, Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-choloform extraction. Anal. Biochem. 162:156–159.
  • Cornelissen G, Halberg F, Stebbings J, Halberg E, Carandente F, Hsi B. (1980). Chronobiometry with pocket calculators and computer systems. Ric. Clin. Lab. 10:333–385.
  • Dardente H, Cermakian N. (2007). Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 24:195–213.
  • Dardente H, Menet JS, Poirel VJ, Streicher D, Gauer F, Vivien-Roels B, Klosen P, Pévet P, Masson-Pévet M. (2003). Melatonin induces Cry1 expression in the pars tuberalis of the rat. Brain Res. Mol. Brain Res. 114:101–106.
  • Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies PJA, Taegtmeyer H. (1998). Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat. Med. 4:1269–1275.
  • Dubocovich ML. (1988). Luzindole (N-0774): a novel melatonin receptor antagonit. J. Pharmacol. Exp. Ther. 246:902–910.
  • Dubocovich ML. (1995). Melatonin receptors: are there multiple subtypes? Trends Pharmacol. Sci. 16:50–56.
  • Dubocovich ML, Mogilnicka E, Areso PM. (1990). Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Eur. J. Pharmacol. 182:313–325.
  • Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI. (2003). Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front. Biosci. 8:d1093–d1108.
  • Duguay D, Cermakian N. (2009). The crosstalk between physiology and circadian clock proteins. Chronobiol. Int. 26:1479–1513.
  • Durgan DJ, Hotze MA, Tomlin TM, Egbejimi O, Graveleau C, Abel ED, Shaw CA, Bray MS, Hardin PE, Young ME. (2005). The intrinsic circadian clock within the cardiomyocyte. Am. J. Physiol. Heart Circ. Physiol. 289:H1530–H1541.
  • Emery P, Reppert SM. (2004). A rhythmic Ror. Neuron 43:443–446.
  • Fukuhara C, Dirden JC, Tosini G. (2002). Regulation of period 1 expression in cultured rat pineal. Neurosignals 11:103–114.
  • Garcia-Mauriño S, Gonzalez-Haba MG, Calvo JR, Rafii-El-Idrissi M, Sanchez-Margalet V, Goberna R, Guerrero JM. (1997). Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol. 159:574–581.
  • Genade S, Genis A, Ytrehus K, Huisamen B, Lochner A. (2008). Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. J. Pineal Res. 45:449–458.
  • Gibson UE, Heid CA, Williams PM. (1996). A novel method for real time quantitative RT-PCR. Genome Res. 6:995–1001.
  • Gillette MU, Mitchell JW. (2002). Signaling in the suprachiasmatic nucleus: selectively responsive and integrative. Cell Tissue Res. 309:99–107.
  • Grossman E, Laudon M, Yalcin R, Zengil H, Peleg E, Sharabi Y, Kamari Y, Shen-Orr Z, Zisapel N. (2006). Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am. J. Med. 119:898–902.
  • Guerrero JM, Pozo D, García-Mauriño S, Osuna C, Molinero P, Calvo JR. (2000). Involvement of nuclear receptors in the enhanced IL-2 production by melatonin in Jurkat cells. Ann. N. Y. Acad. Sci. 917:397–403.
  • Heid CA, Stevens J, Livak KJ, Williams PM. (1996). Real time quantitative PCR. Genome Res. 10:986–994.
  • Kim EJ, Yoo YG, Yang WK, Lim YS, Na TY, Lee IK, Lee MO. (2008). Transcriptional activation of HIF-1 by RORα and its role in hypoxia signaling. Arterioscler. Thromb. Vasc. Biol. 28:1796–1802.
  • Laitinen S, Staels B. (2003). Potential roles of ROR-alpha in cardiovascular endocrinology. Nucl. Recept. Signal. 1:pe011.
  • Lima FB, Machado UF, Bartol I, Seraphim PM, Sumida DH, Moraes SM, Hell NS, Okamoto MM, Saad MJ, Carvalho CR, Cipolla-Neto J. (1998). Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am. J. Physiol. 275:E934–E941.
  • Lochner A, Genade S, Davids A, Ytrehus K, Moolman JA. (2006). Short- and long-term effects of melatonin on myocardial post-ischemic recovery. J. Pineal Res. 40:56–63.
  • Lotufo CM, Lopes C, Dubocovich ML, Farsky SH, Markus RP. (2001). Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur. J. Pharmacol. 430:351–357.
  • Masson-Pévet M. (2007). Melatonin in the circadian system. J. Soc. Biol. 201:77–83.
  • Maywood ES, O'Brien JA, Hastings MH. (2003). Expression of mCLOCK and other circadian clock-relevant proteins in the mouse suprachiasmatic nuclei. J. Neuroendocrinol. 15:329–334.
  • Naji L, Carrillo-Vico A, Guerrero JM, Calvo JR. (2004). Expression of membrane and nuclear melatonin receptors in mouse peripheral organs. Life Sci. 74:2227–2236.
  • Nakajima Y, Ikeda M, Kimura T, Honma S, Ohmiya Y, Honma K. (2004). Bidirectional role of orphan nuclear receptor RORalpha in clock gene transcriptions demonstrated by a novel reporter assay system. FEBS Lett. 565:122–126.
  • Nelson W, Tong YL, Lee JK, Halberg F. (1979). Methods for cosinor-rhythmometry. Chronobiologia 6:305–323.
  • Nonaka H, Emoto N, Ikeda K, Fukuya H, Rohman MS, Raharjo SB, Yagita K, Okamura H, Yokoyama M. (2001). Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation 104:1746–1748.
  • Oishi K, Sakamoto K, Okada T, Nagase T, Ishida N. (1998). Antiphase circadian expression between Bmal1 and period homologue mRNA in the suprachiasmatic nucleus and peripheral tissues of rats. Biochem. Biophys. Res. Commun. 253:199–203.
  • Okamura H, Yamaguchi S, Yagita K. (2002). Molecular machinery of the circadian clocks in mammals. Cell Tissue Res. 309:47–56.
  • Peliciari-Garcia RA, Marçal AC, Silva JA, Carmo-Buonfiglio D, Amaral FG, Afeche SC, Cipolla-Neto J, Carvalho CR. (2010). Insulin temporal sensitivity and its signaling pathway in the rat pineal gland. Life Sci. 87:169–174.
  • Poirel VJ, Boggio V, Dardente H, Pevet P, Masson-Pévet M, Gauer F. (2003). Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mRNA expression in the rat suprachiasmatic nuclei. Neuroscience 120:745–755.
  • Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biologic rhythm research on animals and human beings. Chronobiol. Int. 27: 1911–1929.
  • Reiter RJ, Tan DX, Manchester LC, Pilar Terron M, Flores LJ, Koppisepi S. (2007). Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv. Med. Sci. 52:11–28.
  • Reppert SM, Weaver DR. (2001). Molecular analysis of mammalian circadian rhythms. Annu. Rev. Physiol. 63:647–676.
  • Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, Russel J. Reiter. (2004). Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res. 36:1–9.
  • Sahna E, Deniz E, Bay-Karabulut A, Burma O. (2008). Melatonin protects myocardium from ischemia-reperfusion injury in hypertensive rats: role of myeloperoxidase activity. Clin. Exp. Hypertens. 30:673–681.
  • Sallinen P, Manttari S, Leskinen H, Ilves M, Vakkuri O, Ruskoaho H, Saarela S. (2007). The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin. J. Pineal Res. 42:254–260.
  • Sato TK, Panda S, Miraglia LJ, Reyes TM, Rudic RD, McNamara P, Naik KA, FitzGerald GA, Kay SA, Hogenesch JB. (2004). Functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 43:527–537.
  • Simko F, Paulis L. (2007). Melatonin as a potential antihypertensive treatment. J. Pineal Res. 42:319–322.
  • Simonneaux V, Ribelayga C. (2003). Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol. Rev. 55:325–395.
  • Skene DJ, Arendt J. (2006). Human circadian rhythms: physiological and therapeutic relevance of light and melatonin. Ann. Clin. Biochem. 43:344–353.
  • Smirnov AN. (2001). Nuclear melatonin receptor. Biochemistry (Mosc.) 66:19–26.
  • Steinhilber D, Brungs M, Werz O, Wiesenberg I, Danielsson C, Kahlen JP, Nayeri S, Schräder M, Carlberg C. (1995). The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J. Biol. Chem. 270:7037–7040.
  • Vieira E, Nilsson EC, Nerstedt A, Ormestad M, Long YC, Garcia-Roves PM, Zierath JR, Mahlapuu M. (2008). Relationship between AMPK and the transcriptional balance of clock-related genes in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 295:E1032–E1037.
  • Von Gall C, Garabette ML, Kell CA, Frenzel S, Dehghani F, Schumm-Draeger PM, Weaver DR, Korf HW, Hastings MH, Stehle JH. (2002). Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin. Nat. Neurosci. 5:234–238.
  • Wagner GC, Johnston JD, Tournier BB, Ebling FJ, Hazlerigg DG. (2007). Melatonin induces gene-specific effects on rhythmic mRNA expression in the pars tuberalis of the Siberian hamster (Phodopus sungorus). Eur. J. Neurosci. 25:485–490.
  • Weaver DR, Capodice CE. (2001). Postmortem stability of melatonin receptor binding and clock-relevant mRNAs in mouse suprachiasmatic nucleus. J. Biol. Rhythms 16:216–223.
  • Wiesenberg I, Missbach M, Kahlen JP, Schräder M, Carlberg C. (1995). Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23:327–333.
  • Witt-Enderby PA, Bennett J, Jarzynka MJ, Firestine S, Melan MA. (2003). Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci. 72:2183–2198.
  • Wurtman RJ, Axelrod J, Phillips LS. (1963). Melatonin synthesis in the pineal gland: control by light. Science 142:1071–1073.
  • Young ME. (2006). The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am. J. Physiol. Heart Circ. Physiol. 290:H1–H16.
  • Young ME, Razenghi P, Taegtmeyer H. (2001a). Clock genes in the heart: characterization and attenuation with hypertrophy. Circ. Res. 88:1142–1150.
  • Young ME, Okerberg KA, Wilson CR, Deferrari DA, Ying J, Guthrie P, Razeghi P, Clubb FJJr, Taegtmeyer H. (2001b). Calcitonin gene-related peptide is not essential for the development of pressure overload-induced hypertrophy in vivo. Mol. Cell. Biochem. 225:43–49.
  • Young ME, Wilson CR, Razenghi P, Guthrie PH, Taegtmeyer H. (2002). Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J. Mol. Cell. Cardiol. 34:223–231.
  • Young MW, Kay SA. (2001). Time zones: a comparative genetics of circadian clocks. Nat. Rev. Genet. 2:702–715.
  • Zeman M, Szántóová K, Stebelová K, Mravec B, Herichová I. (2009). Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR(mRen2)27 rats. J. Hypertens. 27( Suppl 6):S21–S26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.